Live from the NIH registry
Studies recruiting near Amarillo right now
Top 25 of 93 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10045 Amarillo, TX Investigational Site — Amarillo, Texas (1.6 mi)
· Sponsor: Colorado Prevention Center
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Harrington Cancer Center ( Site 0061) — Amarillo, Texas (1.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
PharmaTex Research, LLC — Amarillo, Texas (1.6 mi)
· Sponsor: Amgen
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: Agendia
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
PharmaTex Research, LLC — Amarillo, Texas (1.6 mi)
· Sponsor: Novo Nordisk A/S
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Texas Tech University Health Sciences Center-Amarillo — Amarillo, Texas (1.6 mi)
· Sponsor: Children's Oncology Group
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
PharmaTex Research, LLC — Amarillo, Texas (1.6 mi)
· Sponsor: Amgen
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Phase 3
Interventional 70 participants sought
Amarillo Urology Research — Amarillo, Texas (1.6 mi)
· Sponsor: UroGen Pharma Ltd.
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: City of Hope Medical Center
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2
Interventional 325 participants sought
Amarillo Urology Research — Amarillo, Texas (1.6 mi)
· Sponsor: CG Oncology, Inc.
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Recurrent or Metastatic Solid Tumors
Phase 1, Phase 2
Interventional 680 participants sought
Texas Oncology - West Texas — Amarillo, Texas (1.6 mi)
· Sponsor: Daiichi Sankyo
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Phase 3
Interventional 600 participants sought
Amarillo Center for Clinical Research — Amarillo, Texas (1.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Texas Tech University Health Sciences Center-Amarillo-63885 — Amarillo, Texas (1.6 mi)
· Sponsor: Boehringer Ingelheim
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: NRG Oncology
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Amarillo, Texas (1.6 mi)
· Sponsor: DalCor Pharmaceuticals
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1020 — Amarillo, Texas (1.6 mi)
· Sponsor: Immunovant Sciences GmbH
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With Diabetes, Overweight With Diabetes
Phase 3
Interventional 1,156 participants sought
Kailera Clinical Site — Amarillo, Texas (1.6 mi)
· Sponsor: Kailera
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
PharmaTex Research, LLC — Amarillo, Texas (1.6 mi)
· Sponsor: Novo Nordisk A/S
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Graves' Disease
Phase 2
Interventional 232 participants sought
Site 100 — Amarillo, Texas (1.6 mi)
· Sponsor: Yarrow Bioscience, Inc.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Texas Oncology - West Texas ( Site 8008) — Amarillo, Texas (1.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Amarillo, TX Investigative Site 10045 — Amarillo, Texas (1.6 mi)
· Sponsor: Colorado Prevention Center
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
Phase 3
Interventional 1,220 participants sought
Research Site — Amarillo, Texas (1.6 mi)
· Sponsor: AstraZeneca
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer
Phase 2
Interventional 131 participants sought
Amarillo Urology Research — Amarillo, Texas (1.6 mi)
· Sponsor: Protara Therapeutics
Caris Biorepository Research Protocol
Cancer, Early Detection of Cancer
N/A
Observational 100,000 participants sought
ObjectiveHealth - Amarillo Premier Research — Amarillo, Texas (1.6 mi)
· Sponsor: Caris Science, Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: NRG Oncology